Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/02/1999 | WO1999061579A2 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE |
12/02/1999 | WO1999061472A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
12/02/1999 | WO1999061471A2 Human transmembrane proteins |
12/02/1999 | WO1999061470A1 Respiratory nitrate reductase alpha subunit |
12/02/1999 | WO1999061469A2 Prostate growth-associated membrane proteins |
12/02/1999 | WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein |
12/02/1999 | WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
12/02/1999 | WO1999061464A1 Process of purifying angiogenesis inhibitors |
12/02/1999 | WO1999061463A1 Novel secreted and membrane-associated proteins and uses therefor |
12/02/1999 | WO1999061462A1 Antisense modulation of cellular adhesion molecule expression and treatment of cellular adhesion molecule-associated diseases |
12/02/1999 | WO1999061460A1 Rna channels in biological membranes |
12/02/1999 | WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor |
12/02/1999 | WO1999061454A1 Silica-guanidiniumthiocyanate dna isolation using casein |
12/02/1999 | WO1999061453A2 priA |
12/02/1999 | WO1999061452A2 acpS |
12/02/1999 | WO1999061399A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
12/02/1999 | WO1999061289A1 Reinforced beam assembly |
12/02/1999 | WO1999061066A2 Convection-enhanced delivery of aav vectors |
12/02/1999 | WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors |
12/02/1999 | WO1999061052A2 Oral immunization with papillomavirus virus-like particles |
12/02/1999 | WO1999061050A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA) |
12/02/1999 | WO1999061049A2 Model for infection by a pathogen using administration of nucleic acids |
12/02/1999 | WO1999061046A1 Parasite antigens |
12/02/1999 | WO1999061043A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1 |
12/02/1999 | WO1999061041A1 Novel peptides |
12/02/1999 | WO1999061034A1 Improved vectors |
12/02/1999 | WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene |
12/02/1999 | WO1999060843A1 Transgenic plants producing a pap ii protein |
12/02/1999 | WO1999060842A2 Plant retroelements and methods related thereto |
12/02/1999 | WO1999060838A1 Organism and method for metal recovery, remediation and separation |
12/02/1999 | WO1999055564A8 Materials and methods for gene therapy |
12/02/1999 | WO1999054477A3 Genetically engineered yeast and mutants thereof for the efficient fermentation of lignocellulose hydrolysates |
12/02/1999 | WO1999053082A3 Hexose carrier proteins |
12/02/1999 | WO1999053041A3 Method for increasing vitamin c content of plants |
12/02/1999 | WO1999053017A3 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene |
12/02/1999 | WO1999052548A3 Conjugate vaccines for the prevention of dental caries |
12/02/1999 | WO1999051774A3 A method for obtaining a plant with a genetic lesion in a gene sequence |
12/02/1999 | WO1999051745A3 Dna immunization against chlamydia infection |
12/02/1999 | WO1999050448A3 Nucleic acid detection method |
12/02/1999 | WO1999050425A3 Regulated apoptosis using chemically induced dimerization of apoptosis factors |
12/02/1999 | WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily |
12/02/1999 | WO1999050281A3 Collagen peptides and uses thereof |
12/02/1999 | WO1999046381A9 Human fgf gene and gene expression products |
12/02/1999 | WO1999046047A3 Detection and characterization of microorganisms |
12/02/1999 | WO1999044063B1 Tumor tissue microarrays for rapid molecular profiling |
12/02/1999 | WO1999043703A8 Method for immunochemically assaying anti-hm1.24 antibody |
12/02/1999 | WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
12/02/1999 | WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
12/02/1999 | WO1999035262A3 Apoptosis inducing molecule ii |
12/02/1999 | WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use |
12/02/1999 | WO1999023238A8 Efficient construction of vectors for gene targeting using phage-plasmid recombination |
12/02/1999 | WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
12/02/1999 | DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene |
12/02/1999 | DE19823834A1 Genetisches Verfahren zur Herstellung von Riboflavin Genetic procedure for the preparation of riboflavin |
12/02/1999 | DE19823216A1 A process for the overexpression and secretion of heterologous proteins |
12/02/1999 | DE19531783C2 Verfahren zur Erhöhung der pflanzlichen Samenproduktion und zur Beschleunigung des Pflanzenwachstums durch zusätzliche plastidäre Pyruvat, Phosphat Dikinase A method for increasing plant seed production and for accelerating the growth of plants by additional plastidic pyruvate phosphate dikinase |
12/02/1999 | CA2745939A1 Mara family helix-turn-helix domains and their methods of use |
12/02/1999 | CA2745131A1 Aav5 vector and uses thereof |
12/02/1999 | CA2726139A1 Polyhdroxyalkanoate biopolymer compositions |
12/02/1999 | CA2343317A1 Novel peptides |
12/02/1999 | CA2338344A1 Hematopoietic progenitor cell gene transduction |
12/02/1999 | CA2334940A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1 |
12/02/1999 | CA2333872A1 Mechanical lock with a cam-driven locking pawl |
12/02/1999 | CA2333667A1 Murd protein and gene of pseudomonas aeruginosa |
12/02/1999 | CA2333281A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes |
12/02/1999 | CA2333159A1 Method |
12/02/1999 | CA2333006A1 Calmodulin related protein |
12/02/1999 | CA2332786A1 Identification of broadly reactive dr restricted epitopes |
12/02/1999 | CA2331833A1 Parasite antigens |
12/02/1999 | CA2331553A1 Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams |
12/02/1999 | CA2331456A1 Reinforced beam assembly |
12/02/1999 | CA2329694A1 Kunitz domain polypeptide and materials and methods for making it |
12/02/1999 | CA2329525A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
12/02/1999 | CA2329515A1 Silica-guanidiniumthiocyanate dna isolation using casein |
12/02/1999 | CA2329513A1 System for reproducing and modulating stability and turnover of rna molecules |
12/02/1999 | CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor |
12/02/1999 | CA2329505A1 Recombinant aav vectors for gene therapy of hemophilia a |
12/02/1999 | CA2329274A1 Interleukin-21 |
12/02/1999 | CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
12/02/1999 | CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene |
12/02/1999 | CA2329246A1 Method for the isolation of ccc plasmid dna |
12/02/1999 | CA2329159A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
12/02/1999 | CA2329157A1 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
12/02/1999 | CA2329156A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
12/02/1999 | CA2329155A1 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions |
12/02/1999 | CA2329150A1 Transgenic plants producing a pap ii protein |
12/02/1999 | CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity |
12/02/1999 | CA2329140A1 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy |
12/02/1999 | CA2329136A1 Oral immunization with papillomavirus virus-like particles |
12/02/1999 | CA2329131A1 Method for recovering soluble protein |
12/02/1999 | CA2329124A1 Sphingosine kinase, cloning, expression and methods of use |
12/02/1999 | CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
12/02/1999 | CA2329072A1 Human transmembrane proteins |
12/02/1999 | CA2329057A1 Demonstrating resistance to antibiotics in microorganisms |
12/02/1999 | CA2329056A1 Cell cycle genes, proteins and uses thereof |
12/02/1999 | CA2329053A1 Human socs proteins |
12/02/1999 | CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
12/02/1999 | CA2328905A1 Prostate growth-associated membrane proteins |
12/02/1999 | CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor |
12/02/1999 | CA2328892A1 Tumor suppressor |